XYNOS KONSTANTINOS (Chief Medical Officer) sold 5.6% of their position (14.02K shares) of REPLIMUNE GROUP, INC. on the open market
Open‑market sale worth $71.2K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/20/2026ACC: 0001104659-26-064526
Officer· Chief Medical Officer
Since Dec 2022
-14.02K
Net shares
Net seller
$71.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
14.02K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−14.02K
Price / share
$5.08
Trade value
$71.24K
% of position
5.6%
5/18/2026
249.69K→235.66K
Total
Net shares
−14.02K
Net value
-$71.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/18/2026 | S · Sale | −14.02K | $5.08 | $71.24K | 5.6% | 249.69K | 235.66K |
| Total | −14.02K | -$71.24K | ||||||
Derivative Transactions0
No derivative transactions reported